• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌中PET参数与Ki-67表达之间的关联

Associations Between PET Parameters and Expression of Ki-67 in Breast Cancer.

作者信息

Surov Alexey, Meyer Hans Jonas, Wienke Andreas

机构信息

Department of Diagnostic and Interventional Radiology, University of Leipzig, Liebigstr. 20, 04103 Leipzig, Germany.

Institute of Medical Epidemiology, Biostatistics, and Informatics, Martin-Luther-University Halle-Wittenberg, Magdeburger Str., 06097 Halle, Germany.

出版信息

Transl Oncol. 2019 Feb;12(2):375-380. doi: 10.1016/j.tranon.2018.11.005. Epub 2018 Dec 3.

DOI:10.1016/j.tranon.2018.11.005
PMID:30522044
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6279710/
Abstract

OBJECTIVES

Numerous studies investigated relationships between positron emission tomography and proliferation index Ki-67 in breast cancer (BC) with inconsistent results. The aim of the present analysis was to provide evident data about associations between standardized uptake value (SUV) and expression of Ki-67 in BC.

METHODS

MEDLINE library, SCOPUS and EMBASE data bases were screened for relationships between SUV and Ki-67 in BC up to April 2018. Overall, 32 studies with 1802 patients were identified. The following data were extracted from the literature: authors, year of publication, number of patients, and correlation coefficients. Associations between SUV and Ki-67 were analyzed by Spearman's correlation coefficient.

RESULTS

Associations between SUV derived from F-FDG PET and Ki-67 were reported in 25 studies (1624 patients). The pooled correlation coefficient was 0.40, (95% CI = [0.34; 0.46]). Furthermore, 7 studies analyzed associations between SUV derived from F-fluorthymidin (FLT) PET and Ki-67 (178 patients). The pooled correlation coefficient was 0.54, (95% CI = [0.37; 0.70]).

CONCLUSION

SUV correlated moderately with expression of Ki-67 and, therefore, cannot be used as a surrogate marker for tumor proliferation. Further studies are needed to evaluate associations between PET parameters and histopathological findings like hormone receptor status in breast cancer.

摘要

目的

众多研究调查了乳腺癌(BC)中正电子发射断层扫描与增殖指数Ki-67之间的关系,但结果不一致。本分析的目的是提供关于标准化摄取值(SUV)与BC中Ki-67表达之间关联的明确数据。

方法

检索MEDLINE数据库、SCOPUS和EMBASE数据库,以查找截至2018年4月BC中SUV与Ki-67之间的关系。总共确定了32项研究,涉及1802例患者。从文献中提取以下数据:作者、发表年份、患者数量和相关系数。通过Spearman相关系数分析SUV与Ki-67之间的关联。

结果

25项研究(1624例患者)报告了F-FDG PET得出的SUV与Ki-67之间的关联。合并相关系数为0.40,(95%CI = [0.34; 0.46])。此外,7项研究分析了F-氟胸腺嘧啶核苷(FLT)PET得出的SUV与Ki-67之间的关联(178例患者)。合并相关系数为0.54,(95%CI = [0.37; 0.70])。

结论

SUV与Ki-67的表达呈中度相关,因此不能用作肿瘤增殖的替代标志物。需要进一步研究来评估PET参数与乳腺癌组织病理学结果(如激素受体状态)之间的关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfb1/6279710/1e8e1cf0c9fc/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfb1/6279710/b433512974cd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfb1/6279710/d996333cb439/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfb1/6279710/1e8e1cf0c9fc/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfb1/6279710/b433512974cd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfb1/6279710/d996333cb439/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfb1/6279710/1e8e1cf0c9fc/gr3.jpg

相似文献

1
Associations Between PET Parameters and Expression of Ki-67 in Breast Cancer.乳腺癌中PET参数与Ki-67表达之间的关联
Transl Oncol. 2019 Feb;12(2):375-380. doi: 10.1016/j.tranon.2018.11.005. Epub 2018 Dec 3.
2
Correlations Between Imaging Biomarkers and Proliferation Index Ki-67 in Lymphomas: A Systematic Review and Meta-Analysis.影像学标志物与淋巴瘤增殖指数 Ki-67 的相关性:系统评价和荟萃分析。
Clin Lymphoma Myeloma Leuk. 2019 Jun;19(6):e266-e272. doi: 10.1016/j.clml.2019.03.005. Epub 2019 Mar 11.
3
Standardized Uptake Values Derived from F-FDG PET May Predict Lung Cancer Microvessel Density and Expression of KI 67, VEGF, and HIF-1 but Not Expression of Cyclin D1, PCNA, EGFR, PD L1, and p53.标准化摄取值源于 F-FDG PET 可能预测肺癌微血管密度和 Ki67、VEGF、HIF-1 的表达,但不能预测 cyclin D1、PCNA、EGFR、PD-L1 和 p53 的表达。
Contrast Media Mol Imaging. 2018 Jun 6;2018:9257929. doi: 10.1155/2018/9257929. eCollection 2018.
4
Can Imaging Parameters Provide Information Regarding Histopathology in Head and Neck Squamous Cell Carcinoma? A Meta-Analysis.影像学参数能否提供有关头颈部鳞状细胞癌组织病理学的信息?一项荟萃分析。
Transl Oncol. 2018 Apr;11(2):498-503. doi: 10.1016/j.tranon.2018.02.004. Epub 2018 Mar 3.
5
Associations Between FDG PET and Expression of VEGF and Microvessel Density in Different Solid Tumors: A Meta-analysis.不同实体瘤中 FDG PET 与 VEGF 表达和微血管密度的相关性:Meta 分析。
Acad Radiol. 2021 Apr;28(4):e110-e117. doi: 10.1016/j.acra.2020.02.030. Epub 2020 Apr 21.
6
Associations Between [F]FDG-PET and Complex Histopathological Parameters Including Tumor Cell Count and Expression of KI 67, EGFR, VEGF, HIF-1α, and p53 in Head and Neck Squamous Cell Carcinoma.头颈部鳞状细胞癌中 [F]FDG-PET 与包括肿瘤细胞计数和 KI67、EGFR、VEGF、HIF-1α 和 p53 表达在内的复杂组织病理学参数之间的关联。
Mol Imaging Biol. 2019 Apr;21(2):368-374. doi: 10.1007/s11307-018-1223-x.
7
FDG PET correlates weakly with HIF-1 expression in solid tumors: a meta-analysis.FDG PET 与实体瘤中 HIF-1 表达的相关性较弱:一项荟萃分析。
Acta Radiol. 2021 Apr;62(4):557-564. doi: 10.1177/0284185120932378. Epub 2020 Jun 19.
8
Correlation between (18)F-FDG uptake on PET/CT and prognostic factors in triple-negative breast cancer.PET/CT上(18)F-FDG摄取与三阴性乳腺癌预后因素的相关性
Eur Radiol. 2015 Nov;25(11):3314-21. doi: 10.1007/s00330-015-3734-z. Epub 2015 Apr 23.
9
[¹⁸F]fluorothymidine-positron emission tomography in patients with locally advanced breast cancer under bevacizumab treatment: usefulness of different quantitative methods of tumor proliferation.贝伐单抗治疗下局部晚期乳腺癌患者的[¹⁸F]氟胸苷正电子发射断层扫描:不同肿瘤增殖定量方法的实用性
Rev Esp Med Nucl Imagen Mol. 2014 Sep-Oct;33(5):280-5. doi: 10.1016/j.remn.2014.01.007. Epub 2014 Jul 23.
10
Parameters of simultaneous 18F-FDG-PET/MRI predict tumor stage and several histopathological features in uterine cervical cancer.同时进行的18F-FDG-PET/MRI参数可预测子宫颈癌的肿瘤分期及多种组织病理学特征。
Oncotarget. 2017 Apr 25;8(17):28285-28296. doi: 10.18632/oncotarget.16043.

引用本文的文献

1
Metabolic Imaging Parameters of F FDG PET/CT in Differentiating the Ki-67 Index in Carcinoma Breast.¹⁸F FDG PET/CT代谢成像参数在鉴别乳腺癌Ki-67指数中的应用
Indian J Nucl Med. 2025 Mar-Apr;40(2):67-71. doi: 10.4103/ijnm.ijnm_168_24. Epub 2025 Jun 27.
2
Novel Molecular Classification of Breast Cancer with PET Imaging.基于PET成像的乳腺癌新型分子分类
Medicina (Kaunas). 2024 Dec 21;60(12):2099. doi: 10.3390/medicina60122099.
3
Does FDG PETCT have a predictive value for neoadjuvant chemotherapy response in nonmetastatic breast cancer?

本文引用的文献

1
FDG-PET/CT and molecular markers to predict response to neoadjuvant chemotherapy and outcome in HER2-negative advanced luminal breast cancers patients.18F-氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)及分子标志物用于预测人表皮生长因子受体2(HER2)阴性晚期管腔型乳腺癌患者对新辅助化疗的反应及预后。
Oncotarget. 2018 Mar 27;9(23):16343-16353. doi: 10.18632/oncotarget.24674.
2
Tumor metabolism assessed by FDG-PET/CT and tumor proliferation assessed by genomic grade index to predict response to neoadjuvant chemotherapy in triple negative breast cancer.基于 FDG-PET/CT 评估肿瘤代谢和基因组分级指数评估肿瘤增殖预测三阴性乳腺癌新辅助化疗反应。
Eur J Nucl Med Mol Imaging. 2018 Jul;45(8):1279-1288. doi: 10.1007/s00259-018-3998-z. Epub 2018 Apr 4.
3
氟代脱氧葡萄糖正电子发射断层扫描计算机断层扫描(FDG PETCT)对非转移性乳腺癌新辅助化疗反应是否具有预测价值?
Ir J Med Sci. 2025 Feb;194(1):31-36. doi: 10.1007/s11845-024-03856-6. Epub 2024 Dec 18.
4
Metabolic Imaging of Advanced Basal Cell Carcinoma Treated with Sonidegib: A Retrospective Case Series Study.用索尼德吉治疗的晚期基底细胞癌的代谢成像:一项回顾性病例系列研究。
J Clin Med. 2024 Aug 27;13(17):5087. doi: 10.3390/jcm13175087.
5
Prognostic significance of  Ga-FAPI PET/CT in patients with bone metastases in various cancers.Ga-FAPI PET/CT 对各种癌症骨转移患者的预后意义。
Ann Nucl Med. 2024 Aug;38(8):630-638. doi: 10.1007/s12149-024-01935-3. Epub 2024 Apr 30.
6
Clinicopathological and molecular predictors of [F]FDG-PET disease detection in HER2-positive early breast cancer: RESPONSE, a substudy of the randomized PHERGain trial.曲妥珠单抗辅助治疗 HER2 阳性早期乳腺癌的临床病理和分子预测因素:来自 PHERGain 试验的随机亚组研究 RESPONSE。
Eur J Nucl Med Mol Imaging. 2024 Jul;51(9):2733-2743. doi: 10.1007/s00259-024-06683-0. Epub 2024 Apr 8.
7
Towards a fast PET/MRI protocol for breast cancer imaging: maintaining diagnostic confidence while reducing PET and MRI acquisition times.针对乳腺癌成像的快速 PET/MRI 协议:在减少 PET 和 MRI 采集时间的同时保持诊断信心。
Eur Radiol. 2023 Sep;33(9):6179-6188. doi: 10.1007/s00330-023-09580-6. Epub 2023 Apr 12.
8
Correlation between Imaging Markers Derived from PET/MRI and Invasive Acquired Biomarkers in Newly Diagnosed Breast Cancer.正电子发射断层扫描/磁共振成像衍生的影像标志物与新诊断乳腺癌侵袭性获得性生物标志物之间的相关性
Cancers (Basel). 2023 Mar 8;15(6):1651. doi: 10.3390/cancers15061651.
9
Comparison of F-fluorothymidine Positron Emission Tomography/Computed Tomography and F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Breast Cancer.氟代胸苷正电子发射断层扫描/计算机断层扫描与氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在乳腺癌患者中的比较。
Tomography. 2022 Oct 11;8(5):2533-2546. doi: 10.3390/tomography8050211.
10
The Value of F-FDG PET/CT Imaging in the Evaluation of Interim Neoadjuvant Chemotherapy Response in Locally Advanced Breast Cancer.F-FDG PET/CT成像在评估局部晚期乳腺癌新辅助化疗中期反应中的价值
Mol Imaging Radionucl Ther. 2022 Jun 27;31(2):123-129. doi: 10.4274/mirt.galenos.2022.44154.
Differential Prognostic Impact of Strong PD-L1 Expression and 18F-FDG Uptake in Triple-negative Breast Cancer.PD-L1强表达和18F-FDG摄取对三阴性乳腺癌的不同预后影响
Am J Clin Oncol. 2018 Nov;41(11):1049-1057. doi: 10.1097/COC.0000000000000426.
4
Breast cancer diagnosis: Imaging techniques and biochemical markers.乳腺癌诊断:影像学技术与生化标志物。
J Cell Physiol. 2018 Jul;233(7):5200-5213. doi: 10.1002/jcp.26379. Epub 2018 Jan 19.
5
Simultaneous whole-body and breast 18F-FDG PET/MRI examinations in patients with breast cancer: a comparison of apparent diffusion coefficients and maximum standardized uptake values.乳腺癌患者的全身与乳腺同时 18F-FDG PET/MRI 检查:表观扩散系数与最大标准化摄取值的比较
Jpn J Radiol. 2018 Feb;36(2):122-133. doi: 10.1007/s11604-017-0707-y. Epub 2017 Nov 20.
6
Assessment of biological and clinical aggressiveness of invasive ductal breast cancer using baseline 18F-FDG PET/CT-derived volumetric parameters.使用基线18F-FDG PET/CT衍生的体积参数评估浸润性导管癌的生物学和临床侵袭性。
Nucl Med Commun. 2018 Jan;39(1):83-93. doi: 10.1097/MNM.0000000000000779.
7
Prognostic value of FDG-PET and DWI in breast cancer.氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)和弥散加权成像(DWI)在乳腺癌中的预后价值。
Ann Nucl Med. 2018 Jan;32(1):44-53. doi: 10.1007/s12149-017-1217-9. Epub 2017 Nov 13.
8
Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of 18F-deoxyglucose levels on positron emission tomography for breast cancers.对于乳腺癌,肿瘤大小和增殖标志物geminin而非Ki67的表达水平与正电子发射断层扫描中18F-脱氧葡萄糖水平的最大摄取显著相关。
PLoS One. 2017 Sep 8;12(9):e0184508. doi: 10.1371/journal.pone.0184508. eCollection 2017.
9
Reliability of F-FDG PET Metabolic Parameters Derived Using Simultaneous PET/MRI and Correlation With Prognostic Factors of Invasive Ductal Carcinoma: A Feasibility Study.使用同步PET/MRI得出的F-FDG PET代谢参数的可靠性及其与浸润性导管癌预后因素的相关性:一项可行性研究。
AJR Am J Roentgenol. 2017 Sep;209(3):662-670. doi: 10.2214/AJR.16.17766. Epub 2017 Jul 5.
10
Multiparametric Evaluation of Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer Using Integrated PET/MR.多参数评估使用整合 PET/MR 在乳腺癌新辅助化疗中的治疗反应。
Clin Nucl Med. 2017 Jul;42(7):506-513. doi: 10.1097/RLU.0000000000001684.